Clinical Trial Update: Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety of etanercept in adults with moderate to severe psoriasis has completed; the update does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Psoriasis | Phase 4 | Status: COMPLETED